MicroPort NeuroTech (Shanghai) Co., Ltd. was established in 2012 and is affiliated with MicroPort NeuroScience Co., Ltd. (referred to as "MicroPort NeuroScience™"). On July 15, 2022, MicroPort NeuroScience™ was listed on the Main Board of the Hong Kong Stock Exchange with stock code 2172.HK. - Covers three major cerebrovascular disease treatment areas: hemorrhagic stroke, atherosclerotic stenosis, and acute cerebral embolism - Covers more than 3,000 hospitals in China - Products have entered 9 of the world's top 10 neurointerventional markets (Spain, the United States, South Korea, Brazil, the United Kingdom, Germany, Japan, Italy, France) - Has multiple innovative products and a mature model of medical-industrial collaboration
What does MicroPort NeuroTech (Shanghai) Co., Ltd. require? Who is MicroPort NeuroTech hiring? MicroPort NeuroTech recruitment: 医疗卫生/美容保健类占比最多占34.4%,其次是在校学生类占34.4%. What education can get in at MicroPort NeuroTech? 本科占比最多占37.5%,其次是大专占34.4%. High education required at MicroPort NeuroTech? 硕士占18.8%. Work experience required at MicroPort NeuroTech? 不限占比最多占50%,其次是3-5年占40.6%. Where are the job locations at MicroPort NeuroTech? 上海占比最多占71.9%,其次是成都占6.3%. Based on job postings from the past year, for reference only.
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows